Clinical Research Directory
Browse clinical research sites, groups, and studies.
Health Information Technology System ("Roadmap 2.0") in the Context of Hematopoietic Cell Transplantation
Sponsor: University of Michigan Rogel Cancer Center
Summary
The purpose of this research study is to measure the effects of using a mobile phone app (Roadmap 2.0) on the health-related quality of life of caregivers and patients undergoing allogeneic/autologous hematopoietic cell transplantation (HCT).
Official title: A Randomized Trial of Roadmap 2.0
Key Details
Gender
All
Age Range
5 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
372
Start Date
2020-09-08
Completion Date
2024-08-11
Last Updated
2026-04-14
Healthy Volunteers
No
Conditions
Interventions
Wearable activity sensor
Caregivers and patients in both arms of the study will have a Fitbit wearable activity sensor to track activity and sleep.
Roadmap 2.0 information system
Caregivers and patients download the Roadmap 2.0 app on their mobile phones or tablets
Survey administration
Caregivers and patients will be asked to respond to survey questions at 3 timepoints.
Roadmap 2.0 information system with Positive Activities
Caregivers and patients download the Roadmap 2.0 app on their mobile phones. Caregivers and patients will be instructed on how to operate Roadmap 1.0 on an iPad (inpatient only) and Roadmap 2.0 on a mobile phone (inpatient and outpatient). Caregivers download the Positive Activities app onto their mobile phone to use freely throughout inpatient and outpatient (through day 120 post-transplant). Caregiver may also use an electronic tablet provided by the study team during the patient's hospital stay.
Locations (2)
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
Oregon Health & Science University
Portland, Oregon, United States